JENNIFER KLEIN: Open Payments
NPI 1669517033 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,061 in 82 payments from 9 companies in 2025. Trend: 2023 $8,047 · 2024 $4,267 · 2025 $6,061
Consulting: $3,340Food & beverage: $2,115Travel & lodging: $606
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $3,652 |
| ViiV Healthcare Company | 33 | $1,630 |
| Merck Sharp & Dohme LLC | 10 | $265 |
| Theratechnologies Inc. | 9 | $227 |
| Novo Nordisk Inc | 5 | $101 |
| EMD Serono, Inc. | 3 | $87 |
| PFIZER INC. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| TerSera Therapeutics LLC | 1 | $19 |
Products named: Sunlenca, DOVATO, PIFELTRO, EGRIFTA, CABENUVA, APRETUDE, RUKOBIA, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
